538PFIRST REPORT OF A PHASE II TRIAL OF IRINOTECAN PLUS S-1...

Annals of Oncology 2014 / 09 Vol. 25; Iss. suppl_4

538PFIRST REPORT OF A PHASE II TRIAL OF IRINOTECAN PLUS S-1 (IRIS) WITH CETUXIMAB (IRIS/CET) IN PRE-TREATED PATIENTS WITH KRAS WILD TYPE OF METASTATIC COLORECTAL CANCER (MCRC): HGCSG0902

Muto, O., Yuki, S., Nakamura, M., Hosokawa, A., Kato, T., Iwanaga, I., Hatanaka, K., Tsuji, Y., Sato, A., Eto, K., Furukawa, K., Okuda, H., Onodera, M., Fujikawa, K., Kudo, M., Yokoyama, S., Honda, T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu333.41
Date:
September, 2014
File:
PDF, 64 KB
2014
Conversion to is in progress
Conversion to is failed